Is third generation anti-citrullinated peptide antibody assay a sensitive marker in rheumatoid factor negative rheumatoid arthritis?
Discrimination between RA and non-RA patients was better using CCP3, most pronounced in RF-negative RA.
These findings expand the repertoire of genes that are mutated in patients with mitochondrial disorders and highlight the value of integrating genomic approaches in the evaluation of these patients.